跳至主要内容
临床试验/NCT00840918
NCT00840918终止不适用

The Effect of Perioperative Intravenous Lidocaine on Postoperative Outcomes After Cardiac Surgery

The Cleveland Clinic1 个研究点 分布在 1 个国家目标入组 123 人开始时间: 2009年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
入组人数
123
试验地点
1
主要终点
atrial fibrillation

研究概览

简要总结

This study is being done to determine if lidocaine, administered during surgery and for 24 hours after surgery can reduce inflammation, thereby reducing the risk of atrial fibrillation and 30 day mortality after surgery. Participants undergoing cardiac surgery will be randomized to receive either lidocaine or placebo.

详细描述

Subjects undergoing cardiac surgery are randomized into one of two groups.

  • Group 1: Intravenous Lidocaine Group
  • Group 2: Intravenous placebo Group

Either Lidocaine or placebo is administered throughout surgery and 24 hours after surgery.

Patients in both groups will undergo quality of life assessments and functional recovery assessments post-surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-90 years old
  • Scheduled for cardiac surgery requiring cardiopulmonary bypass
  • Written informed consent

排除标准

  • Off-pump surgical procedures
  • Anticipated deep hypothermic circulatory arrest
  • Any contraindications to the proposed interventions including lidocaine allergy
  • History of preoperative atrial fibrillation
  • Baseline Screening revealing preexisting dementia or delirium
  • Preoperative liver failure defined as Child-Pugh Score > 6

研究组 & 干预措施

1

Active Comparator

Intravenous Lidocaine group

干预措施: Lidocaine (Drug)

Placebo

Placebo Comparator

Intravenous placebo Group - Placebo is administered intravenously throughout surgery and during the 24 hours following surgery

干预措施: Placebo (Other)

结局指标

主要结局

atrial fibrillation

时间窗: postoperatively

To test the hypothesis that lidocaine infusion started at induction of anesthesia and maintained for 24 hours postoperatively will decrease the incidence of atrial fibrillation compared to an intravenous saline control.

mortality

时间窗: 30 days post surgery

To test the hypothesis that lidocaine infusion started at induction of anesthesia and maintained for 24 hours postoperatively will decrease the incidence of 30 day mortality as compared to an intravenous saline control.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验